Yearly Archives: 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 9 April 2024) has been published and includes articles on: Topical steroids: introduction of new labelling and a reminder of the possibility of severe side effects, including Topical Steroid Withdrawal Reactions Letters and medicine recalls sent to healthcare professionals in [...]

The post MHRA Drug Safety Update: May 2024 appeared first on Community Pharmacy England.

As part of our commitment to engaging with pharmacy owners and LPCs, Community Pharmacy England will be holding a series of regional roadshow events across the country.  Taking place through July, the events will see Chief Executive Janet Morrison and her team, as well as Committee Members, visiting every NHS England region to hear directly [...]

The post Pharmacy Owner Events Programme appeared first on Community Pharmacy England.

We have received several queries regarding the deadline for claiming payments and when pharmacy owners will receive payments for the Pharmacy First service. The service specification states, “Claims for payments should be submitted within one month of, and no later than three months from the claim period for the chargeable activity provided”. Therefore, if you [...]

The post Claiming and payment schedule for Pharmacy First appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Somatropin (NutropinAq®) 10mg/2ml solution for injection cartridges Somatropin (Humatrope®) 6mg, 12mg and 24mg powder and solvent for solution for injection cartridges MSN/2024/064 Tier 2 – medium impact Date of issue: 29th May 2024 Somatropin (NutropinAq®) 10mg/2ml solution for injection cartridges have [...]

The post Medicine Supply Notification: Somatropin (NutropinAq® ) 10mg/2ml solution for injection cartridges Somatropin (Humatrope® ) 6mg, 12mg and 24mg powder and solvent for solution for injection cartridges appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Memantine (Valios®) 10mg and 20mg orodispersible tablets sugar free MSN/2024/063 Tier 2 – medium impact Date of issue: 29th May 2024 Valios® 10mg and 20mg orodispersible tablets are out of stock until late August 2024 Valios® 5mg orodispersible tablets remain available [...]

The post Medicine Supply Notification: Memantine (Valios® ) 10mg and 20mg orodispersible tablets sugar free appeared first on Community Pharmacy England.